UnitedHealth raises 2026 profit outlook after Q2 earnings beat

Traders Union
All News
Financial News
UnitedHealth raises 2026 profit outlook

Highlights

UnitedHealth raises its 2026 adjusted earnings outlook to $19.50–$20 per share, up from over $18.25, with revenue guidance above $439 billion.
Q2 adjusted EPS reached $6.38 (vs. $4.90 expected) and revenue hit $112.03 billion (vs. $110.85 billion expected), driven by turnaround efforts and AI implementation.
UnitedHealthcare membership fell 525,000 to 48.5 million in Q2 due to higher costs and premium hikes, with further losses forecast for 2026, offset by higher pricing.

Turnaround plan boosts earnings outlook

As reported by CNBC, UnitedHealth says it now expects 2026 adjusted earnings of $19.50 to $20 per share, up from its previous outlook of more than $18.25 per share, while maintaining revenue guidance of more than $439 billion. Chief Financial Officer Wayne DeVeydt says the company could outperform that revenue target after a stronger-than-expected second quarter.

The insurer reports adjusted earnings per share of $6.38 for the quarter, ahead of analysts' expectation of $4.90, while revenue reaches $112.03 billion versus the expected $110.85 billion, according to LSEG data cited in the report. Net income rises to $5.48 billion, or $6.04 per share, from $3.41 billion, or $3.74 per share, a year earlier.

Management says restructuring and executive changes are helping the company stabilize margins. DeVeydt says the turnaround is translating into stronger earnings, but adds that the effort remains a multi-year journey rather than a sign that medical cost trends are returning to normal.

UnitedHealth says it is using artificial intelligence to improve efficiency and patient care, including faster prior authorization processes and better payment accuracy through detection of potential fraud, waste and abuse. DeVeydt says AI tools are not deciding whether care is approved or denied.

Higher costs reshape membership and pricing

Medical costs remain elevated above historical levels in the quarter, DeVeydt says, underscoring pressure that has affected the broader insurance sector for more than two years. UnitedHealth says higher healthcare costs are forcing insurers to raise premiums and adjust benefits, contributing to membership losses in Affordable Care Act exchange plans and privately run Medicare Advantage plans.

UnitedHealthcare serves 48.5 million people in the second quarter, down 525,000 from the previous quarter. DeVeydt says affordability pressures are a main driver, and forecasts losses of roughly 500,000 exchange members and 1.1 million Medicare Advantage members in 2026.

The company says revenue remains stable because higher pricing is offsetting lower enrollment, though DeVeydt warns that this dynamic is not positive for the healthcare system over the long term. Costs for delayed post-pandemic care and expensive specialty medicines such as GLP-1s continue to weigh on insurers, especially those with Medicare Advantage exposure.

UnitedHealth's medical benefit ratio improves to 86.7% in the second quarter from 89.4% a year earlier, beating analysts' expectation of 88.5%, according to StreetAccount. The results also come about a year after the company disclosed Department of Justice investigations into its Medicare billing practices, and DeVeydt says UnitedHealth has no update but remains supportive of the probe.

DOJ scrutiny of Medicare billing practices was in focus in our earlier report on Labcorp’s $14.5 million settlement over allegations of medically unnecessary urine drug testing billed to Medicare Part B. We outlined how regulators are targeting testing and coding practices that may prioritize revenue over medical necessity, as part of a broader federal push to curb fraud, waste and abuse in healthcare programs.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.